NCT00268840View on ClinicalTrials.gov

The Efficacy and Safety of Gemcitabine in Combination With Docetaxel to Treat Pancreatic or Biliary Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

August 31, 2001

Primary Completion Date

February 28, 2006

Study Completion Date

February 28, 2006

Conditions
Pancreatic NeoplasmsBiliary Tract Neoplasms
Interventions
DRUG

Docetaxel

Docetaxel 50 mg/m2 ou 35 mg/m² (suivant le bilan hépatique) à J1 et J15 toutes les 4 semaines

DRUG

Gemcitabine

Gemcitabine 1200 mg/m2 à J1 et J15 toutes les 4 semaines

Trial Locations (1)

75004

Hôpital Hôtel Dieu, Paris

All Listed Sponsors
lead

ARCAGY/ GINECO GROUP

OTHER

NCT00268840 - The Efficacy and Safety of Gemcitabine in Combination With Docetaxel to Treat Pancreatic or Biliary Cancer | Biotech Hunter | Biotech Hunter